Evidence map›Paper›PMID 31068995›Full record

ReviewThe Pan African medical journal2018

Cutaneous leiomyosarcoma on the trunk: An unusual presentation with an aggressive course - Case report and review of literature.

Lina Hmida, Feryel Letaief, Raoudha Doghri, Khedija Meddeb, Khalil Mahjoubi, Amina Mokrani, Yosra Yahiaoui, Azza Gabsi, Nesrine Cheraiet, Henda Rais and 2 more

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in The Pan African medical journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Advanced Cutaneous Leiomyosarcoma of the Forearm.Dermatopathology (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Lina HmidaMedical Oncology Department, Salah Azaiez Institute, Tunis, Tunisie.
Feryel LetaiefMedical Oncology Department, Salah Azaiez Institute, Tunis, Tunisie.
Raoudha DoghriAnatomic Pathology Department, Salah Azaiez Institute, Tunis, Tunisie.
Khedija MeddebMedical Oncology Department, Salah Azaiez Institute, Tunis, Tunisie.
Khalil MahjoubiRadiotherapy Department, Salah Azaiez Institute, Tunis, Tunisie.
Amina MokraniMedical Oncology Department, Salah Azaiez Institute, Tunis, Tunisie.
Yosra YahiaouiMedical Oncology Department, Salah Azaiez Institute, Tunis, Tunisie.
Azza GabsiMedical Oncology Department, Salah Azaiez Institute, Tunis, Tunisie.
Nesrine CheraietMedical Oncology Department, Salah Azaiez Institute, Tunis, Tunisie.
Henda RaisMedical Oncology Department, Salah Azaiez Institute, Tunis, Tunisie.
Mouna AyadiMedical Oncology Department, Salah Azaiez Institute, Tunis, Tunisie.
Amel MezliniMedical Oncology Department, Salah Azaiez Institute, Tunis, Tunisie.
Institut Salah-Azaïz · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary cutaneous leiomyosarcoma (PCL) are soft-tissue sarcoma, arising in the dermis, with or without extension into the subcutis. They are thought to have an indolent course compared to their subcutaneous counterparts, they may recur but rarely metastases. We report the case of a patient with a PCL arising in the anterior trunk wall who developed pulmonary, bone and retroperitoneal metastases 6 years after wide surgical excision of the primary tumor.

Indexed as

AdultBone NeoplasmsFollow-Up StudiesHumansLeiomyosarcomaLung NeoplasmsMaleRetroperitoneal NeoplasmsSkin NeoplasmsTime FactorsTorsochemotherapyLeiomyosarcoma cutaneoussurgery

Identifiers

PMID31068995
PMCPMC6492208
OpenAlexW2901046793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.